Management of convulsive status epilepticus in children

Archives of Disease in Childhood: Education and Practice Edition

Volumn 94, Issue 1, 2009, Pages 1-9

  Yoong, M ^a,b   Chin, R F M ^a,b   Scott, R C ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c YOUNG EPILEPSY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; FOSPHENYTOIN SODIUM; LORAZEPAM; MIDAZOLAM; PARALDEHYDE; PHENOBARBITAL; PHENYTOIN; ANTICONVULSIVE AGENT;

CHILD; CONVULSIVE STATUS EPILEPTICUS; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EPILEPTIC STATE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; TREATMENT INDICATION; CLINICAL PROTOCOL; DRUG COMBINATION;

ANTICONVULSANTS; CHILD; CLINICAL PROTOCOLS; DRUG THERAPY, COMBINATION; HUMANS; STATUS EPILEPTICUS;

EID: 61449102686     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2007.134049     Document Type: Review

References (76)

1. Chin RF, Neville BG, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 2006;368:222-9.
2. Raspall-Chaure M, Chin RF, Neville BG, et al. Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol 2006;5:769-79.
3. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993;34:592-6.
4. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia 1999;40:120-2.
5. Patel H, Scott E, Dunn D, et al. Nonepileptic seizures in children. Epilepsia 2007;48:2086-92.
6. Tuxhorn IE, Fischbach HS. Pseudostatus epilepticus in childhood. Pediatr Neurol 2002;27:407-9.
7. Stokes T, Shaw EJ, Juarez-Garcia A, et al. Clinical guidelines and evidence review for the epilepsies: diagnosis and management in adults and children in primary and secondary care. London: Royal Co ege of Genera Practitioners, 2004.
8. Lipka K, Bulow HH. Lactic acidosis following convulsions. Acta Anaesthesiol Scand 2003;47:616-18.
9. The Advanced Life Support Group. Advanced paediatric life support: the practical approach. 4th ed. Oxford: Blackwell Publishing, 2004.
10. National Institute for Health and Clinical Excellence. CG47 Feverish illness in young children: full guidance. Available from http://www.nice.org.uk/guidance/index.jsp7action = download&o = 30525 (accessed 18 November 2008).
11. Chin RF, Neville BG, Scott RC. Meningitis is a common cause of convulsive status epilepticus with fever. Arch Dis Child 2005;90:66-9.
12. Riviello JJ Jr, Ashwal S, Hirtz D, et al. Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006;67:1542-50.
13. The AGREE Collaboration. AGREE Instrument. Available from http://www.agreecollaboration.org/instrument/ (accessed 18 November 2008).
14. Chin RF, Verhulst L, Neville BG, et al. Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J Neurol Neurosurg Psychiatry 2004;75:1584-8.
15. Chin RF, Neville BG, Peckham C, et al. Treatment of community- onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol 2008;7:696-703.
16. Tobias JD, Berkenbosch JW. Management of status epilepticus in infants and children prior to pediatric ICU admission: deviations from the current guidelines. South Med J 2008;101:268-72.
17. Muayqil T, Rowe BH, Ahmed SN. Treatment adherence and outcomes in the management of convulsive status epilepticus in the emergency room. Epileptic Disord 2007;9:43-50.
18. Tirupathi S, Webb D, McMenamin J. Factors influencing admission to ICU in children presenting with status epilepticus. Dev Med Child Neurol 2008;50(s112):6.
19. National Institute for Health and Clinical Excellence. CG20 Epilepsy in adults and children: full guideline, appendix C (corrected). Available from http://www.nice.org.uk/guidance/ index.jsp?action=download&o= 29536 (accessed 18 November 2008).
20. Appleton R, Choonara I, Martland T, et al. The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party. Arch Dis Child 2000;83:415-19.
21. New South Wales Government Department of Health. Children and infants with seizures - acute management. Available from http://www.health.nsw. gov.au/policies/pd/2006/ PD2006-023.html (accessed 18 November 2008).
22. Riviello JJ Jr, Holmes GL. The treatment of status epilepticus. Semin Pediatr Neurol 2004;11:129-38.
23. Nolan M, Beca J, Trenholme A, et al. Convulsive status epilepticus in infants (age >1 month), children and adolescents. Auckland, New Zealand: Starship Children's Health, 2004. Available from http://www.starship.org.nz/Clinical%20Guideline%20PDFs/Convulsions%20- %20Status%20Epilepticus.pdf (accessed 18 November 2008).
24. Sugai K. Treatment of convulsive status epilepticus in infants and young children in Japan. Acta Neurol Scand Suppl 2007;186:62-70.
25. Verity CM. Do seizures damage the brain? The epidemiological evidence. Arch Dis Child 1998;78:78-84.
26. Fabene PF, Merigo F, Galie M, et al. Pilocarpine-induced status epilepticus in rats involves ischemic and excitotoxic mechanisms. PLoS ONE 2007;2:e1105.
27. Lemos T, Cavalheiro EA. Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp Brain Res 1995;102:423-8.
28. Covolan L, Mello LE. Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus. Epilepsy Res 2000;39:133-52.
29. Klitgaard H, Matagne A, Vanneste-Goemaere J, et al. Pilocarpine- induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations. Epilepsy Res 2002;51:93-107.
30. Pohlmann-Eden B, Gass A, Peters CN, et al. Evolution of MRI changes and development of bilateral hippocampal sclerosis during long lasting generalised status epilepticus. J Neurol Neurosurg Psychiatry 2004;75:898-900.
31. Tsuchida TN, Barkovich AJ, Bollen AW, et al. Childhood status epilepticus and excitotoxic neuronal injury. Pediatr Neurol 2007;36:253-7.
32. Nixon J, Bateman D, Moss T. An MRI and neuropathological study of a case of fatal status epilepticus. Seizure 2001;10:588-91.
33. Shinnar S. Who is at risk for prolonged seizures? J Child Neurol 2007;22(5 Suppl):14S-20S.
34. Shinnar S, Berg AT, Moshe SL, et al. How long do new-onset seizures in children last? Ann Neurol 2001;49:659-64.
35. Mazarati AM, Baldwin RA, Sankar R, et al. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998;814:179-85.
36. Eghbali M, Curmi JP, Birnir B, et al. Hippocampal GABA(A) channel conductance increased by diazepam. Nature 1997;388:71-5.
37. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1995;36(Suppl 2):S2-12.
38. Sperk G. Changes in GABAA receptors in status epilepticus. Epilepsia 2007;48(Suppl 8):11-13.
39. Deshpande LS, Blair RE, Nagarkatti N, et al. Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus. Exp Neurol 2007;204:705-13.
40. Jones DM, Esmaeil N, Maren S, et al. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res 2002;50:301-12.
41. Knudsen FU. Rectal administration of diazepam in solution in the acute treatment of convulsions in infants and children. Arch Dis Child 1979;54:855-7.
42. Mpimbaza A, Ndeezi G, Staedke S, et al. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics 2008;121:e58-e64.
43. McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005;366:205-10.
44. Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999;353:623-6.
45. Wilson MT, Macleod S, O'Regan ME. Nasal/buccal midazolam use in the community. Arch Dis Child 2004;89:50-1.
46. Scott RC, Besag FM, Boyd SG, et al. Buccal absorption of midazolam: pharmacokinetics and EEG pharmacodynamics. Epilepsia 1998;39:290-4.
47. Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev 2008;(3):CD001905.
48. Garr RE, Appleton RE, Robson WJ, et al. Children presenting with convulsions (including status epilepticus) to a paediatric accident and emergency department: an audit of a treatment protocol. Dev Med Child Neurol 1999;41:44-7.
49. Stewart WA, Harrison R, Dooley JM. Respiratory depression in the acute management of seizures. Arch Dis Child 2002;87:225-6.
50. Ramsey-Williams VA, Wu Y, Rosenberg HC. Comparison of anticonvulsant tolerance, crosstolerance, and benzodiazepine receptor binding following chronic treatment with diazepam or midazolam. Pharmacol Biochem Behav 1994;48:765-72.
51. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of- hospital status epilepticus. N Engl J Med 2001;345:631-7.
52. Joint Royal Colleges Ambulance Liaison Committee. Paediatric - convulsions in children. Nottingham, UK: JRCALC, 2007. Available from http://www2.warwick.ac.uk/fac/med/research/hsri/emergencycare/jrcalc-2006/ guidelines/ (accessed 18 November 2008).
53. Curless RG, Holzman BH, Ramsay RE. Paraldehyde therapy in childhood status epilepticus. Arch Neurol 1983;40:477-80.
54. Mountain R, Ferguson S, Fowler A, et al. Noncardiac pulmonary edema following administration of parenteral paraldehyde. Chest 1982;82:371-2.
55. Ohaegbulam SC. Peripheral nerve injuries from intramuscular injection of drugs. West Afr J Pharmacol Drug Res 1976;3:161-7.
56. Ahmad S, Ellis JC, Kamwendo H, et al. Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. Lancet 2006;367:1591-7.
57. Githiga IM, Muchohi SN, Ogutu BR, et al. Determination of paraldehyde by gas chromatography in whole blood from children. J Chromatogr B Analyt Technol Biomed Life Sci 2004;805:365-9.
58. Chin RF, Neville BG, Peckham C, et al. An analysis of first and second line treatments for convulsive status epilepticus in childhood. Dev Med Child Neurol 2005;47(Suppl 101):7.
59. Wilder BJ. Efficacy of phenytoin in treatment of status epilepticus. Adv Neurol 1983;34:441-6.
60. Brevoord JC, Joosten KF, Arts WF, et al. Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin. J Child Neurol 2005;20:476-81.
61. Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet 2003;42:33-58.
62. Rudis MI, Touchette DR, Swadron SP, et al.Cost-effectivenessof oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department. Ann Emerg Med 2004;43:386-97.
63. Burneo JG, Anandan JV, Barkley GL. A prospective study of the incidence of the purple glove syndrome. Epilepsia 2001;42:1156-9.
64. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-8.
65. Gilbert DL, Glauser TA. Complications and costs of treatment of refractory generalized convulsive status epilepticus in children. J Child Neurol 1999;14:597-601.
66. Owens MJ, Nemeroff CB. Pharmacology of valproate. Psychopharmacol Bull 2003;37(Suppl 2):17-24.
67. Agarwal P, Kumar N, Chandra R, et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007;16:527-32.
68. Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol 2007;22:1191-7.
69. Knake S, Gruener J, Hattemer K, et al. Intravenous levetiracetam in the treatment of benzodiazepine-refractory status epilepticus. J Neurol Neurosurg Psychiatry 2007;79:588-9.
70. Trabacca A, Profice P, Costanza MC, et al. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report. J Child Neurol 2007;22:639-41.
71. Patel NC, Landan IR, Levin J, et al. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15:137-41.
72. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205-10.
73. Lambrechtsen FA, Buchhalter JR. Aborted and refractory status epilepticus in children: a comparative analysis. Epilepsia 2007;49:615-25.
74. Neville BG, Chin RF, Scott RC. Childhood convulsive status epilepticus: epidemiology, management and outcome. Acta Neurol Scand Suppl 2007;186:21-4.
75. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-35.
76. Paediatric Formulary Committee. BNFC 2008. London: BMJ Publishing Group, RPS Publishing and RCPCH Publications, 2008. See www.bnfc.org (accessed 18 November 2008).